Zyclara

Zyclara (Imiquimod) is a topical cream used to treat certain skin conditions. It works by activating the body's immune response to target affected areas. This medication is commonly used for actinic keratosis and superficial basal cell carcinoma.

Zyclara (Imiquimod) is primarily used to treat actinic keratosis, a pre-cancerous skin condition caused by sun exposure. It is also prescribed for superficial basal cell carcinoma, a type of skin cancer. The cream helps reduce abnormal skin cells by stimulating the immune system to target and eliminate them.

When applied as directed, Zyclara (Imiquimod) may cause redness, itching, or mild irritation at the application site. Some users report temporary discomfort or flaking of the skin during treatment. These effects are generally mild and resolve after completing the course.

Avoid applying Zyclara (Imiquimod) to open wounds, broken skin, or sunburned areas. Use only as prescribed and avoid excessive sun exposure during treatment. Keep the medication away from eyes, lips, and mucous membranes. Wash hands thoroughly after application.

Zyclara (Imiquimod) has not been shown to interact significantly with other medications. However, avoid using other topical treatments on the same area unless directed by a healthcare provider. Alcohol and certain other substances may increase skin sensitivity during use.